Macro - In the first half of the year, listed companies achieved operating income of 35.01 trillion yuan, a year-on-year increase of 0.16%; net profit reached 3 trillion yuan, with a year-on-year growth of 2.54%, an increase of 4.76 percentage points compared to the previous year's full-year growth [3][4] - In August, the manufacturing PMI was 49.4%, up 0.1 percentage points month-on-month; the non-manufacturing business activity index was 50.3%, up 0.2 percentage points month-on-month; the composite PMI output index was 50.5%, up 0.3 percentage points month-on-month [3] - Several banks indicated that they continued to support the stabilization of the real estate market in the first half of the year by increasing mortgage loan issuance, with the second-hand housing loan issuance increasing by over 20% year-on-year [4] Convertible Bonds - In August, the convertible bond market continued to be active, with the convertible bond index rising by 4.32%, underperforming the overall market index which rose by 10.74% [6] - The high-priced convertible bond index outperformed low-priced and mid-priced indices, with an increase of 8.92% in August, indicating stronger performance in a rising equity market [6][9] - The dual-low strategy underperformed in a strong market, with only a 2.48% increase in August, while the high-priced low-premium strategy rose by 7.07% [9] Traditional Chinese Medicine Industry - Shouxiangu reported a 16.51% decrease in operating income to 300 million yuan in the first half of 2025, with a net profit decline of 33.99% to 65.56 million yuan [14] - The company expects performance to improve in the third quarter, as July saw a return to positive growth in revenue [15] - The company is expanding its online channels, with internet sales increasing by 15.14% year-on-year, while traditional sales channels are being enhanced through strategic partnerships [16] Innovative Drug Industry - Sanofi's half-year report showed a revenue of 4.36 billion yuan, a slight decrease of 0.8%, while net profit increased by 24.6% to 1.36 billion yuan [20] - The company is focusing on innovative therapies, with several products in clinical trials, including SSGJ-707, which has potential for significant market value [21] - Existing products are performing steadily, with a notable increase in sales in the hair loss segment, while other segments are experiencing slight fluctuations [22] Medical Equipment - Ruimait's half-year performance was strong, with a revenue of 544 million yuan, a year-on-year increase of 42.30%, and a net profit of 131 million yuan, also up 42.19% [25] - The company has improved its expense ratios significantly, with a sales expense ratio of 10.43%, down 2.24 percentage points year-on-year [26] - The rebranding to "Ruimait" is expected to enhance brand value and market penetration, aligning the company's identity with its core products [28]

债券研究 可转债研究 正股行情延续，转债精选板块 相关研究： 证券研究报告 2025 年 09 月 01 日 湘财证券研究所 核心要点： ❑ 8 月权益市场交投持续活跃，转债继续跑输正股 根据 Wind 数据，8 月（8.1-8.29）中证转债指数上涨 4.32%，中证全指上涨 10.74%；年初至今，中证转债指数、中证全指分别上涨 14.85%、20.49%。8 月权益市场延续了较高的成交活跃度，市场风险偏好明显上升，因此转债 表现整体弱于正股，中证转债指数分别跑输沪深 300、中证 500 指数 6pct、 9pct。 按价格分类看，8 月万得高价转债指数涨幅（+8.92%）大幅领先于低价 （+3.14%）和中价指数（+3.26%），连续 4 个月大幅上涨。主要原因在于 高价转债股性较强，在权益市场持续上行期具备更强的跟涨能力，另一方 面则体现出资金对于当前行情持续性的确认。年初至今，高价转债指数累 计上涨 20.35%，尤其是 7-8 月显著跑赢中价、低价指数。 ❑ 科技板块延续强势表现，但涨幅仍不及正股 根据 Wind 一级行业分类，8 月信息技术转债指数上涨 6.62%，延续了上月 的强劲表现，全年 ...

Group 1: Report Industry Investment Rating - No relevant content provided Group 2: Core Views of the Report - In July, the equity market rose significantly, but convertible bonds underperformed the underlying stocks. The CSI Convertible Bond Index rose 3.83%, while the CSI All-Share Index rose 5.8%. Year-to-date, the CSI Convertible Bond Index and the CSI All-Share Index rose 11.11% and 10.33% respectively [2][11]. - The healthcare sector was strong, and convertible bonds followed the upward trend but still underperformed the underlying stocks. The healthcare and information technology convertible bond indices had the best performance in July, with increases of 7.82% and 7.13% respectively [3][21]. - The double-low strategy should pay more attention to the valuation elasticity of the underlying stocks. It is recommended to focus on the more growth-oriented AI and robotics sectors [4]. Group 3: Summary According to the Directory 1. Convertible Bond Monthly Market Tracking - In terms of price classification, in July, the Wande High-Price Convertible Bond Index rose 5.84%, significantly leading the low-price (+4.27%) and medium-price indices (+2.72%). Year-to-date, the cumulative increases of low-price and high-price convertible bonds were basically the same, both higher than that of medium-price convertible bonds [2][13]. - By convertible bond issue size, in July, the small-cap and mid-cap convertible bond indices performed strongly, with increases of 4.47% and 4.02% respectively, higher than the large-cap convertible bond index (+3.11%). Year-to-date, the small-cap index had a significant lead [16]. - By credit rating, in July, the AA+ and AA convertible bond indices had relatively large increases. Throughout the year, low-rated convertible bonds still significantly outperformed high-rated ones [17]. - In terms of sectors, in July, the healthcare and information technology convertible bond indices performed best. The financial convertible bond index only rose 0.47% this month, while the underlying stocks rose 3.69% [3][21]. - Driven by the sharp rise of the underlying stocks, in July, the double-low strategy significantly underperformed the high-price low-premium strategy. The double-low strategy index rose only 2.36% in July, while the high-price low-premium strategy rose 7.29% [26]. 2. Convertible Bond Monthly Investment Recommendations 2.1 Strategy Recommendation: The Double-Low Strategy Should Focus on the Valuation Elasticity of the Underlying Stocks - The double-low portfolio constructed in July had 22 targets. From July 1st to 30th, the portfolio return was 1.78%, underperforming the CSI Convertible Bond Index by 2 pct [29]. - In August, 15 individual bonds were selected. The average convertible bond price, conversion value, and conversion premium rate of the portfolio were 124 yuan, 117 yuan, and 7% respectively [32]. 2.2 Allocation Recommendation: Focus on the More Growth-Oriented AI and Robotics Sectors - The current market risk appetite has significantly recovered. Using high-price low-premium convertible bonds to replace the underlying stocks can better obtain the returns from the rise of the underlying stocks. It is recommended to focus on the technology sector, especially AI and robotics [34].